Drug Safety Matters
En podcast af Uppsala Monitoring Centre
48 Episoder
-
#31 A guide to reporting disproportionality analyses – Michele Fusaroli and Daniele Sartori
Udgivet: 30.9.2024 -
Uppsala Reports Long Reads – Weeding out duplicates to better detect side effects
Udgivet: 26.8.2024 -
Uppsala Reports Long Reads – Ensuring trust in AI/ML when used in pharmacovigilance
Udgivet: 27.6.2024 -
#30 Preventing and reporting medication errors – Rabat CC & UMC
Udgivet: 15.5.2024 -
#29 When medicines change our behaviour – Michele Fusaroli
Udgivet: 23.4.2024 -
#28 Catching black swans – François Montastruc
Udgivet: 29.2.2024 -
#27 When drugs damage the liver – Rita Baião
Udgivet: 1.2.2024 -
#26 What's trending in pharmacovigilance? – Angela Caro
Udgivet: 20.12.2023 -
#25 A week in the name of medicines safety – part 2
Udgivet: 13.11.2023 -
#24 A week in the name of medicines safety – part 1
Udgivet: 2.11.2023 -
Uppsala Reports Long Reads – The colour of signals
Udgivet: 29.9.2023 -
Uppsala Reports Long Reads – Empowering patients as partners
Udgivet: 5.9.2023 -
#23 Assessing safety in clinical trials – Marianne Lunzer & Sanja Prpić
Udgivet: 27.6.2023 -
#22 Reforming pharmacovigilance education – Michael Reumerman
Udgivet: 8.5.2023 -
#21 Unlocking the power of real-world data – Patrick Ryan
Udgivet: 30.3.2023 -
#20 The evidence for signals – Daniele Sartori
Udgivet: 23.2.2023 -
Uppsala Reports Long Reads – Unmasking data in the COVID-19 vaccine era
Udgivet: 26.1.2023 -
#19 Lessons in pandemic pharmacovigilance – Elena Rocca
Udgivet: 15.12.2022 -
#18 The IDMP standards explained – Malin Fladvad & Olle Lagerlund
Udgivet: 29.9.2022 -
#17 Why we need vaccine surveillance systems – Madhava Balakrishnan
Udgivet: 24.8.2022
Drug Safety Matters brings you the best stories from the world of pharmacovigilance. Through in-depth interviews with our guests, we cover new research and trends, and explore the most pressing issues in medicines safety today. Produced by Uppsala Monitoring Centre, the WHO Collaborating Centre for International Drug Monitoring.